Market OverviewThe Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

My dad is a type-two diabetic who needs to use an insulin pen before every meal, so finding a solution to this question was extremely vital. After researching potential options, I came across Frio ...

That is the date that you can open the insulin and begin using it by. Once you open a vial of insulin or pen, another expiration date starts. Generally, insulin expires 28 days after it's opened ...

Novo Nordisk has made its smart insulin pens available in the UK ... trend to make medicines safer and more effective through the use of digital technologies. The new devices – NovoPen 6 ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Further, another major finding concerns insulin pen injection devices, which are preferred by diabetics, as against using multiple syringes each day to inject insulin out of vials. Due to their ...